dm+d
322822007
Articles
Managing medicines for people with sulfonamide allergy
2 October 2024
Medicine Compliance Aid Stability
genericNon-proprietary
Non-proprietary
generic
Tablets 50mg, 100mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special storage conditions.
20 December 2022
ImigranGlaxoSmithKline UK
GlaxoSmithKline UK
Imigran
Tablets 50mg, 100mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special storage requirements
23 November 2022
Imigran RadisGlaxoSmithKline UK
GlaxoSmithKline UK
Imigran Radis
Tablets f/c 50mg, 100mg
A2 · Amber 2No stability data is available, the manufacturer does not, or cannot recommend use in CAs but there are no theoretical concerns with the product.
No special precautions for storage
No special storage requirements
23 November 2022
Lactation Safety Information
Preferred choice for treatment of acute migraine or cluster headache
Limited published evidence of safety which shows very small amounts in breast milk
Poor oral bioavailability, so amount absorbed by infant is likely to be too low to cause adverse effects.
As a precaution, monitor for drowsiness, vomiting, and changes in feeding
12 September 2022